Abiomed Recalls Impella Optical Controllers Due to Software and Hardware Defects
Abiomed is recalling 179 Impella Optical Controllers worldwide due to defects that may cause pump failure, loss of control, or inaccurate pressure readings.
The agency’s classification
FDA (Devices): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as Class I due to hazards including loss of control of the heart pump console and pump failure. The source text does not report any illnesses, injuries, or deaths.
Plain-English summary
Abiomed, Inc. is recalling 179 units of the Impella Optical Controller, the primary user control interface for the Impella Catheter, a catheter-based heart pump. The recall covers units distributed in the United States and 30 foreign countries, including Belgium, Brazil, Canada, and the United Kingdom.
A retrospective review of servicing records identified units requiring hardware, firmware, or software updates to address four specific issues. First, an RFID firmware issue may cause the controller to fail to recognize the purge cassette, potentially delaying procedures. Second, the rotary push button may stick, leading to unreliable actuation and a loss of control of the console. Third, the controller may experience instability resulting in start-up failure or an inability to drive the pump. Fourth, a software defect may cause calculator process crashes, leading to negative Central Venous Pressure values in Pulmonary Artery Pressure calculations.
The source text does not report any illnesses, injuries, or deaths associated with these defects. The recall is classified as Class I by the FDA, indicating a reasonable probability that use of the violative product will cause serious adverse health consequences or death.
The recalled product
- Product
- Impella Optical Controller, Packaged. Primary user control interface for the Impella Catheter, a catheter-based heart pump.
- Manufacturer
- Abiomed, Inc.
- Category
- Medical Device — Cardiac Support
- Affected units
- 179
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Product Code: 0042-0010-US
- 0042-0010-UK
- 0042-0010-EU
- 0042-0010-IN
- UDI: 00813502010985
- 00813502010978
- 00813502010961
- 00813502011425
- Serial No. IC6962
- IC7004
- IC7036
- IC7170
- IC7213
- IC7214
- IC7239
- IC7241
- IC7677
- IC7787
- IC7880
- IC8105
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Abiomed, Inc.
See all →- SevereAbiomed Recalls 428 Automated Impella Controllers for Hardware and Software Defects
FDA (Devices) · 2026-11-04
- SevereAbiomed Recalls Impella Connect Optical AIC Units for Hardware and Software Defects
FDA (Devices) · 2026-11-04
- HighAbiomed Recalls Automated Impella Controllers Due to Firmware and Software Defects
FDA (Devices) · 2026-09-30
- SevereAbiomed Recalls Automated Impella Controllers Due to Purge Sensor Defect
FDA (Devices) · 2026-09-23
- SevereAbiomed Recalls Impella Optical Controllers Due to Purge Sensor Defect
FDA (Devices) · 2026-09-23
Same hazard · loss of control
See all →- Severe
- SevereCummins Recalls Meritor Drivelines Due to Missing Snap Ring
NHTSA · 2026-10-28
- SevereForeign Tire Recalls Otani Tires Due to Tread Separation Risk
NHTSA · 2026-10-28
- SevereHyundai Recalls 2026 Models for Wheel Lug Nut Loosening Risk
NHTSA · 2026-10-21
- SevereFord Recalls Lincoln Hybrid Vehicles for Transmission Defect
NHTSA · 2026-10-20